Early evidence of inherited risk for the development of pulmonary fibrosis was based on twin studies and familial aggregation of cases [
7‐
10]. Even though these early studies suggested an inherited risk, the first specific disease associated gene variants were identified after 2000 and included surfactant protein mutations among familial cases of pulmonary fibrosis [
11‐
14], specifically in the genes for surfactant protein C (
SFTPC) and
SFTPCA [
12,
14,
15]. There are also rare familial syndromes associated with pulmonary fibrosis, such as Hermansky–Pudlak syndrome. This disorder is caused by defects in intracellular protein trafficking, such as mutations in
AP3B1, which are central to this genetically heterogeneous autosomal recessive disorder [
16,
17].
Pulmonary fibrosis also occurs in dyskeratosis congenita, a syndrome characterized by aplastic anemia, myelodysplastic syndrome, skin hyperpigmentation, nail dystrophy, and pulmonary and liver fibrosis [
18,
19]. There are a number of genetic mutations associated with dyskeratosis congenita, including mutations in dyskeratosis congenita 1 (
DKC1), a gene involved in the stabilization of telomeres [
18], as well as in other telomerase genes [
19], pointing to telomeropathy as a potential underlying mechanism for fibrosis. Investigations of familial IPF cases and their kindred identified germline mutations in the telomerase genes telomerase reverse transcriptase (
TERT) and telomerase RNA component (
TERC) in up to one-sixth of pulmonary fibrosis families [
19‐
21]. Importantly,
TERT and
TERC mutations were present in cases of both familial and sporadic IPF, and individuals with these mutations had shorter telomeres when compared to age-matched family members without mutations [
22]. Recent studies by Cogan and colleagues describe rare variants in the genes encoding regulator of telomere elongation helicase 1 (
RTEL1) and polyadenylation-specific ribonuclease deadenylation nuclease (
PARN) associated with familial disease. These rare variants were found through exome-sequencing of familial interstitial pneumonia (FIP) cases [
23,
24]. Patients with these variants had profound shortening of telomeres in peripheral blood mononuclear cells, though the mechanism by which loss of
PARN affects telomere length is unknown. These newly described rare variants further point to telomere length’s being important in the pathogenesis of IPF [
23,
24].